FDA-approved product exists

Oxytocin

FDA-approved

Oxytocin has FDA-approved prescription products (OXYTOCIN (ANDA091676), OXYTOCIN (ANDA200219), OXYTOCIN (NDA018243), OXYTOCIN (NDA018248), PITOCIN (NDA018261)). Oxytocin is not on FDA's 503B Bulks List for outsourcing facilities (list checked 2026-07-25). 50 registered ClinicalTrials.gov studies cite Oxytocin (28 completed, 10 unknown, 4 recruiting, 4 withdrawn, 2 terminated, 1 enrolling by invitation, 1 not yet recruiting); registration is not evidence of approval, efficacy, or safety. CompoundedGuide is verifying compounding status, safety signals, and current evidence. This is not medical advice.

What we've verified

Product status: FDA-approved: OXYTOCIN (ANDA091676), OXYTOCIN (ANDA200219), OXYTOCIN (NDA018243), OXYTOCIN (NDA018248), PITOCIN (NDA018261)
Still checking: Compounding status, shortage status, safety signals

Verified sources

openFDA Drugs@FDA P0 · retrieved 2026-07-25
503B Bulks List and Interim Categories P0 · retrieved 2026-07-25
ClinicalTrials.gov API v2 P0 · retrieved 2026-07-25

Research and evidence

FDA-approved product exists cite Oxytocin. Registration is not evidence of approval, efficacy, or safety.

Browse every trial and publication for Oxytocin →

For developers

JSON record Markdown Source packet